Hosted on MSN1mon
FDA extends review of Fortress Biotech's CUTX-101 drug
The NDA for CUTX-101, developed for treating patients with Menkes disease, is being managed by Sentynl Therapeutics, Inc., which took over full responsibility for the drug's development and ...
Business Wire26d
Credit Union of Texas Selects Spiral to Empower Financial Wellness and Community Impact Through Everyday Banking
NEW YORK--(BUSINESS WIRE)--Spiral, the award-winning personalized banking platform, today announced a partnership with Credit Union of Texas (CUTX), a leading Texas-based credit union with a long ...